An unusual T-cell surface phenotype in vivo correlates with the failure to proliferate and produce IL-2 in vitro in a patient with common variable immunodeficiency
Stimulation of T-lymphocytes derived from some patients with common variable immunodeficiency (CVID) syndrome results in defective proliferation. The underlying mechanism is related to the inability of stimulated cells to secrete IL-2 while the expression of IL-2 receptor (IL-2R) is normal. We have identified a patient whose peripheral T-cells failed to proliferate and secrete IL-2 upon stimulation. The addition of recombinant IL-2 restored proliferation. The defect did not seem to be caused by accessory cell failure since the patient's adherent cells produced IL-1 and IL-6, and addition of allogeneic irradiated cells did not induce proliferation. Stimulation of CVID T-cells with phorbol esters and Ca2+ ionophore induced both IL-2 secretion and proliferation, indicating the absence of a defect in the transcription and/or translation of the IL-2 gene. The patient's T-cells expressed high levels of CD3. The majority of T-cells expressed the CD38 molecule which is normally found on thymocytes or activated T-cells but not peripheral blood T-cells and HLA-DR, another activation marker. However, CD25 (the IL-2R) and CD1, a marker of more immature thymocytes, were not expressed. Finally, the patient's cells were sensitive to an in vitro corticosteroid treatment. The possibilities that this patient's T-cells represent anergic T-cells or not fully matured thymocytes are discussed.
Medienart: |
Artikel |
---|
Erscheinungsjahr: |
1992 |
---|---|
Erschienen: |
1992 |
Enthalten in: |
Zur Gesamtaufnahme - volume:65 |
---|---|
Enthalten in: |
Clinical immunology and immunopathology - 65(1992), 3 vom: 15. Dez., Seite 261-70 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Vukmanović, S [VerfasserIn] |
---|
Anmerkungen: |
Date Completed 07.01.1993 Date Revised 19.08.2019 published: Print Citation Status MEDLINE |
---|
Förderinstitution / Projekttitel: |
|
---|
PPN (Katalog-ID): |
NLM012607355 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM012607355 | ||
003 | DE-627 | ||
005 | 20231221053047.0 | ||
007 | tu | ||
008 | 231221s1992 xx ||||| 00| ||eng c | ||
028 | 5 | 2 | |a pubmed24n0042.xml |
035 | |a (DE-627)NLM012607355 | ||
035 | |a (NLM)1280540 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Vukmanović, S |e verfasserin |4 aut | |
245 | 1 | 3 | |a An unusual T-cell surface phenotype in vivo correlates with the failure to proliferate and produce IL-2 in vitro in a patient with common variable immunodeficiency |
264 | 1 | |c 1992 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
338 | |a Band |b nc |2 rdacarrier | ||
500 | |a Date Completed 07.01.1993 | ||
500 | |a Date Revised 19.08.2019 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Stimulation of T-lymphocytes derived from some patients with common variable immunodeficiency (CVID) syndrome results in defective proliferation. The underlying mechanism is related to the inability of stimulated cells to secrete IL-2 while the expression of IL-2 receptor (IL-2R) is normal. We have identified a patient whose peripheral T-cells failed to proliferate and secrete IL-2 upon stimulation. The addition of recombinant IL-2 restored proliferation. The defect did not seem to be caused by accessory cell failure since the patient's adherent cells produced IL-1 and IL-6, and addition of allogeneic irradiated cells did not induce proliferation. Stimulation of CVID T-cells with phorbol esters and Ca2+ ionophore induced both IL-2 secretion and proliferation, indicating the absence of a defect in the transcription and/or translation of the IL-2 gene. The patient's T-cells expressed high levels of CD3. The majority of T-cells expressed the CD38 molecule which is normally found on thymocytes or activated T-cells but not peripheral blood T-cells and HLA-DR, another activation marker. However, CD25 (the IL-2R) and CD1, a marker of more immature thymocytes, were not expressed. Finally, the patient's cells were sensitive to an in vitro corticosteroid treatment. The possibilities that this patient's T-cells represent anergic T-cells or not fully matured thymocytes are discussed | ||
650 | 4 | |a Case Reports | |
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 7 | |a Adrenal Cortex Hormones |2 NLM | |
650 | 7 | |a Antigens, CD |2 NLM | |
650 | 7 | |a Antigens, CD1 |2 NLM | |
650 | 7 | |a Antigens, Differentiation |2 NLM | |
650 | 7 | |a CD3 Complex |2 NLM | |
650 | 7 | |a HLA-DR Antigens |2 NLM | |
650 | 7 | |a Interleukin-2 |2 NLM | |
650 | 7 | |a Membrane Glycoproteins |2 NLM | |
650 | 7 | |a Receptors, Antigen, T-Cell |2 NLM | |
650 | 7 | |a Receptors, Interleukin-2 |2 NLM | |
650 | 7 | |a Calcimycin |2 NLM | |
650 | 7 | |a 37H9VM9WZL |2 NLM | |
650 | 7 | |a ADP-ribosyl Cyclase |2 NLM | |
650 | 7 | |a EC 3.2.2.5 |2 NLM | |
650 | 7 | |a CD38 protein, human |2 NLM | |
650 | 7 | |a EC 3.2.2.5 |2 NLM | |
650 | 7 | |a ADP-ribosyl Cyclase 1 |2 NLM | |
650 | 7 | |a EC 3.2.2.6 |2 NLM | |
650 | 7 | |a Tetradecanoylphorbol Acetate |2 NLM | |
650 | 7 | |a NI40JAQ945 |2 NLM | |
700 | 1 | |a Vucković, S |e verfasserin |4 aut | |
700 | 1 | |a Stosić-Grujicić, S |e verfasserin |4 aut | |
700 | 1 | |a Ramić, Z |e verfasserin |4 aut | |
700 | 1 | |a Abinun, M |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Clinical immunology and immunopathology |d 1973 |g 65(1992), 3 vom: 15. Dez., Seite 261-70 |w (DE-627)NLM000015296 |x 0090-1229 |7 nnns |
773 | 1 | 8 | |g volume:65 |g year:1992 |g number:3 |g day:15 |g month:12 |g pages:261-70 |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 65 |j 1992 |e 3 |b 15 |c 12 |h 261-70 |